Naslov
Structural 5-day weight loss program ; results of 3 months follow-up

Autori
Matovinović Osvatić, Martina ; Baretić, Maja ; Rabađija, Nada ; Bival, Sandra ; Pavić, Eva ; Uroić, Valentina ; Jakšić, Nenad ; Vuksan Ćusa, Bjanka

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Diabetologia Croatica 2016 Supplement 1 Vol 45- Knjiga sažetaka Godišnjeg sastanka Hrvatskog društva za endokrinologiju i dijabetologiju HLZa / - , 2017, 26-26

Skup
Godišnji sastanak Hrvatskog društva za endokrinologiju i dijabetologiju HLZa

Mjesto i datum
Brijuni, Hrvatska, 13.10.2017. - 15.10.2017

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Domaća recenzija

Ključne riječi
Weight loss ; Structural program ; Obestiy

Sažetak
Data from 58 obese patients (13 men, 45 women), mean age 45 years (20-68), attending structural weight loss program at the Division of Endocrinology, University Hospital Centre Zagreb, were analysed. A 5-day program included daily consultations with a multidisciplinary healthcare team. The team led by an endocrinologist-diabetologist and nurse- educator, also included a nutritionist, physiotherapist, psychiatrist, psychologist who provided psychological support and facilitated behaviour modifications and other subspecialists. At the baseline and after 3 months we estimated anthropometric values (height, weight, BMI) as well as body composition measured by bioelectrical impedance analysis (fat mass, muscle mass). Baseline mean body mass was 125 kg (78-238), BMI was 44.2 kg/m2 (30-66), fat mass 59.4 kg (25.1-120.4), muscle mass 61.4 kg (43.8-117) ; after 3 months mean body mass was 119 kg (72.8-197.3), BMI 42.1 kg/m2 (27.9-64.4), fat mass 53.6 kg (23.6- 103.7), muscle mass 62.3 kg (43.7-107.7). Statistical analyses showed significant decrease in body weight, BMI and body fat mass after 3 months (p=0.000), but no significant difference in muscle mass (p=0.969). Patients were divided into two groups ; those who did not lose any weight (≤1 kg) were considered non- responders, others were considered responders. Thirteen patients (22%) were non- responders, and 45 patients (78%) were responders. Mean weight loss of responders was 6.2% (1-38). According to FDA Guidance for developing products for weight management the product is effective if there is a statistically significant decrease in body weight of ≥5% beyond the placebo effect or at least 35% of patients lose ≥5% of their body weight at 3 months. In conclusion, overall response to our structured program is effective during the 3 months follow-up period. It is fulfilling criteria for weight management products even without pharmacotherapy. The overall weight loss corresponds to fat mass, with preserved muscle mass.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti, Nutricionizam

POVEZANOST RADA